Genomic data for alternate production strategies.: I.: Identification of major contaminating species for cobalt+2 immobilized metal affinity chromatography

被引:13
作者
Cai, Y
Moore, M
Goforth, R
Henry, R
Beitle, R
机构
[1] Univ Arkansas, Dept Chem Engn, Fayetteville, AR 72701 USA
[2] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA
[3] Univ Arkansas, Dept Biol & Agr Engn, Fayetteville, AR 72701 USA
关键词
immobilized metal affinity chromatography; proteomics; Escherichia coli;
D O I
10.1002/bit.20212
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recent advances in technology have allowed for the identification of complex protein mixtures in a rapid fashion. This report highlights the use of 2D gel electrophoresis, mass spectrometry, and database analysis to determine contaminating species of the Escherichia coli genome that are present during immobilized metal affinity chromatography (IMAC), highlighting Co+2 as the affinity ligand. Four proteins (triosephosphate isomerase, alpha galactosiclase, Hsp90, and glucosamine 6-phosphate synthase) constitute the majority of E. coli proteins that bind and potentially may coelute during chromatography. Results are discussed within the context of changes that when implemented could lead to an increase in IMAC efficiency, not by altering column conditions, but rather by changing the nature of the nuisance proteins that principally reduce column capacity and extend processing times. Such a study illustrates the use of proteome data to aid in bioprocess design. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 29 条
[1]   NITROGEN TRANSFER IN ESCHERICHIA-COLI GLUCOSAMINE-6P SYNTHASE - INVESTIGATIONS USING SUBSTRATE AND BISUBSTRATE ANALOGS [J].
BADETDENISOT, MA ;
LERICHE, C ;
MASSIERE, F ;
BADET, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) :815-820
[2]   ONE-STEP PURIFICATION OF A MODEL PERIPLASMIC PROTEIN FROM INCLUSION-BODIES BY ITS FUSION TO AN EFFECTIVE METAL-BINDING PEPTIDE [J].
BEITLE, RR ;
ATAAI, MM .
BIOTECHNOLOGY PROGRESS, 1993, 9 (01) :64-69
[3]  
BERRY A, 2000, Patent No. 15976
[4]   Combined modality management of breast cancer: Development of predictive markers through proteomics [J].
Chakravarthy, B ;
Pietenpol, JA .
SEMINARS IN ONCOLOGY, 2003, 30 (04) :23-36
[5]  
Cheng B, 2000, BIOTECHNOL BIOENG, V70, P467, DOI 10.1002/1097-0290(20001120)70:4<467::AID-BIT13>3.0.CO
[6]  
2-4
[7]   An experimental and theoretical study of the inhibition of Escherichia coli lac operon gene expression by antigene oligonucleotides [J].
Cheng, B ;
Fournier, RL ;
Relue, PA ;
Schisler, J .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 74 (03) :220-229
[8]  
CROSS R, 1973, INTRO SEPARATION SCI, P469
[9]  
Ferguson RE, 2004, CONTRIB NEPHROL, V141, P257
[10]  
Giometti CS, 2003, ADV PROTEIN CHEM, V65, P353